|
|
||||||||
1 Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
2 Department of Pediatrics, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
3 Department of Microbial Genomics, Keygene NV, Agro Business Park 90, 6708 PW Wageningen, The Netherlands
4 Department of Bioinformatics, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
5 PathoFinder BV, Oxfordlaan 70, 6229 EV Maastricht, The Netherlands
6 Laboratory of Pediatric Infectious Diseases, University Medical Center St Radboud, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Correspondence
Damian C. Melles
d.melles{at}erasmusmc.nl
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
We aimed to determine whether the capacity of Staph. aureus to compete with Strep. pneumoniae is dependent on bacterial genotype, the main question being whether certain successful staphylococcal clones are better equipped to compete with pneumococci. We also studied demographic and bacteriological determinants of carriage of specific genotypes of Staph. aureus in children.
| METHODS |
|---|
|
|
|---|
Demographics.
Demographic information was obtained from each child through a standardized questionnaire which was completed under supervision of an instructed interviewer. Questions addressed gender, date of birth, zip code, and active and passive smoking habits. In our analysis we grouped zip codes into four categories (north, south, centre and suburbs of Rotterdam).
DNA isolation and bacterial genotyping.
The 400 Staph. aureus isolates were grown on Columbia III agar (Becton Dickinson) supplemented with 5 % sheep blood. Three to five colonies were suspended in 25 mM Tris, 10 mM EDTA, 50 mM glucose containing lysostaphin (50 µg ml1) and incubated at 37 °C for 1 h. DNA was extracted with the MagNA Pure LC DNA Isolation Kit III using the MagNA Pure LC robot (Roche Diagnostics) and stored at 20 °C. High-throughput amplified fragment length polymorphism (ht-AFLP) analysis was performed as described by Melles et al. (2004)
. AFLP is a whole-genome typing method that scans for polymorphism in actual restriction sites but also among the nucleotides bordering these sites. As such it documents nucleotide sequence variation, insertions and deletions across genomes. Briefly, using the predictive software package Recomb, the optimal enzyme and primer combinations were selected. Bacterial DNA was digested with the enzymes MboI and Csp6I, and the linker oligonucleotide pairs for MboI (5'-CTCGTAGACTGCGTACC-3' and 5'-GATCGGTACGCAGTCTAC-3') and for Csp6I (5'-GACGATGAGTCCTGAC-3' and 5'-TAGTCAGGACTCAT-3') were ligated. Subsequently, a non-selective pre-amplification was performed using the MboI primer (5'-GTAGACTGCGTACCGATC-3') and Csp6I primer (5'-GACGATGAGTCCTGACTAC-3'). In the final amplification, a 33P-labelled MboI primer containing one selective nucleotide (either +C or +G) and a Csp6I primer containing two selective nucleotides (+TA) were used. Amplified material was analysed using standard polyacrylamide slab gels and subsequent autoradiography. Marker fragments were scored, and a binary table, scoring marker fragment absence (0) or presence (1), was compiled.
Pneumococcal DNA was extracted (from 578 of the 598 pneumococcal isolates) and analysed by restriction fragment end labelling (RFEL) as described before (van Steenbergen et al., 1995
; Bogaert et al., 2006
). Briefly, purified pneumococcal DNA was digested by the restriction enzyme EcoRI. The DNA restriction fragments were end-labelled at 72 °C with [
-32P]dATP using DNA polymerase (Goldstar; Eurogentec). After the radiolabelled fragments had been denatured and separated electrophoretically on a 6 % polyacrylamide sequencing gel containing 8 M urea, the gel was transferred onto filter paper, vacuum dried (HBI, Saddlebrook, NY, USA), and exposed for variable times at room temperature to ECL hyperfilm (Amersham Laboratories).
Multilocus sequence typing (MLST).
MLST was carried out for a selection of 45 of the Staph. aureus strains using DNA arrays (van Leeuwen et al., 2003
). The selected strains were equally distributed across an AFLP dendrogram by selecting approximately 1 out of 10 carriage strains isolated from healthy children, going from top to bottom through the AFLP dendrogram (Melles et al., 2004
).
Data analysis.
Analysis of the AFLP data was performed as described by Melles et al. (2004)
. The method used for 2D clustering of the AFLP data was agglomerative (successive) hierarchical. This was performed using the unweighted pair group method with arithmetic means (UPGMA). The similarity metric used was Tanimoto, which defines similarity for binary data (0 and 1) based on the number of positive attributes that two records have in common. The resulting dendrogram was ordered by mean value.
Principal component analysis (PCA) is a standard multivariate method used to reduce the dimensional space of the data to its principal components (PCs). PCA aims to reduce a large number of variables to a smaller set that explain most of the variation in the data. It is, basically, a rotation of axes after centering data to the means of the variables, the rotated axes being the PCs, which are linear combinations of the original variables. The PC computation is displayed as a 3D scatter plot in which the position along the axes shows the PCA score of the strain. The distribution of the strains in the four phylogenetic branches was defined on the basis of PCA. Hierarchical and PCA cluster analysis was performed using Spotfire DecisionSite 7.2 software (http://www.spotfire.com).
To compare the distribution of strain categories in different genetic clusters, chi-squared analysis was used. Logistic regression analysis was used to adjust for possible confounding factors. A two-sided P-value of 0.05 or less was considered significant.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
|
|
|
|
However, passive smoking was significantly associated with carriage of Staph. aureus AFLP-cluster IV (P=0.003; see also footnote to Table 2
). An earlier study had already revealed that passive smoking is associated with an increased risk of Staph. aureus colonization, with active smoking being protective against colonization (Bogaert et al., 2004
). This suggests that passive smoking excites colonization opportunities for specific genotypes of Staph. aureus that have been shown to be possibly hypervirulent before (AFLP cluster IV) (Melles et al., 2004
). We additionally performed logistic regression analysis with AFLP cluster IV as outcome, and active smoking, passive smoking, age, gender, co-colonization and zip code as possible confounders in the model. This analysis revealed that passive smoking was independently associated with carriage of AFLP cluster IV (odds ratio 2.8; confidence interval 1.55.5; P=0.002). Additional statistical analysis of the different subclusters from major AFLP clusters I and IV (dotted lines in Fig. 1
) did not reveal novel associations with carriage of specific Staph. aureus genotypes (data not shown).
In our search for factors co-determining success of colonization with certain Staph. aureus genotypes, we found no evidence for involvement of age, gender, zip code, active smoking and co-colonization with N. menigitidis and vaccine or non-vaccine serotypes of Strep. pneumoniae. This suggests that with respect to Staph. aureus, bacterial inter-species competition in the nasopharynx probably depends on host characteristics or currently unspecified microbial features (e.g. receptor and ligands), rather than AFLP-defined overall Staph. aureus genotypes. Further studies involving molecular typing or gene expression testing at a more detailed level may still generate data that could help identify strain- rather than clone-specific factors involved in baterial interference. Maturation of the nasopharyngeal niche, including its diverse innate immunity factors during ageing, might be an important driving force, but this hypothesis should be substantiated by further investigations. Recently, it was suggested that hydrogen peroxide production by Strep. pneumoniae is important in the bacterial interference process, a lead that warrants further investigation (Regev-Yochay et al., 2006
). In conclusion, neither of the staphylococcal clones identified by AFLP has a better competitive edge over the pneumococcus. Thus, success of Staph. aureus clones is not explained on the basis of improved competition with co-colonizing pneumococci. Furthermore, we found an association between passive smoking and carriage of a specific Staph. aureus cluster in children.
| ACKNOWLEDGEMENTS |
|---|
AFLP is a registered trademark of Keygene NV and the AFLP® technology is covered by patents (US 6 045 994A, EP0534858B1) and patent applications owned by Keygene NV.
Edited by: J. M. van Dijl
| REFERENCES |
|---|
|
|
|---|
Bogaert, D., van Belkum, A., Sluijter, M., Luijendijk, A., de Groot, R., Rumke, H. C., Verbrugh, H. A. & Hermans, P. W. (2004). Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363, 18711872.[CrossRef][Medline]
Bogaert, D., Sluijter, M., Toom, N. L., Mitchell, T. J., Goessens, W. H., Clark, S. C., de Groot, R. & Hermans, P. W. (2006). Dynamics of pneumococcal colonization in healthy Dutch children. Microbiology 152, 377385.
Cole, A. M., Dewan, P. & Ganz, T. (1999). Innate antimicrobial activity of nasal secretions. Infect Immun 67, 32673275.
Cole, A. M., Tahk, S., Oren, A., Yoshioka, D., Kim, Y. H., Park, A. & Ganz, T. (2001). Determinants of Staphylococcus aureus nasal carriage. Clin Diagn Lab Immunol 8, 10641069.[CrossRef][Medline]
Foster, T. J. (2004). The Staphylococcus aureus "superbug". J Clin Invest 114, 16931696.[CrossRef][Medline]
Herz, A. M., Greenhow, T. L., Alcantara, J., Hansen, J., Baxter, R. P., Black, S. B. & Shinefield, H. R. (2006). Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect Dis J 25, 293300.[CrossRef][Medline]
Koning, S., van Belkum, A., Snijders, S., van Leeuwen, W., Verbrugh, H., Nouwen, J., Op't Veld, M., van Suijlekom-Smit, L. W., van der Wouden, J. C. & Verduin, C. (2003). Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol 41, 30173021.
Luzar, M. A., Coles, G. A., Faller, B., Slingeneyer, A., Dah, G. D., Briat, C., Wone, C., Knefati, Y., Kessler, M. & Peluso, F. (1990). Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 322, 505509.[Abstract]
McNally, L. M., Jeena, P. M., Gajee, K., Sturm, A. W., Tomkins, A. M., Coovadia, H. M. & Goldblatt, D. (2006). Lack of association between the nasopharyngeal carriage of Streptococcus pneumoniae and Staphylococcus aureus in HIV-1-infected South African children. J Infect Dis 194, 385390.[CrossRef][Medline]
Melles, D. C., Gorkink, R. F., Boelens, H. A., Snijders, S. V., Peeters, J. K., Moorhouse, M. J., van der Spek, P. J., van Leeuwen, W. B., Simons, G. & other authors (2004). Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 114, 17321740.[CrossRef][Medline]
Moss, B., Squire, J. R. & Topley, E. (1948). Nose and skin carriage of Staphylococcus aureus in patients receiving penicillin. Lancet 1, 320325.[CrossRef]
Nguyen, M. H., Kauffman, C. A., Goodman, R. P., Squier, C., Arbeit, R. D., Singh, N., Wagener, M. M. & Yu, V. L. (1999). Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 130, 221225.
Nouwen, J., Ott, A., Boelens, H., Claassen, M., van Belkum, A., Hofman, A. & Verbrugh, H. A. (2004). Smoking pattern and fasting glucose levels determine Staphylococcus aureus nasal carriage. PhD thesis, Erasmus University Medical Center, Rotterdam, The Netherlands.
Peacock, S. J., de Silva, I. & Lowy, F. D. (2001). What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 9, 605610.[CrossRef][Medline]
Peacock, S. J., Justice, A., Griffiths, D., de Silva, G. D., Kantzanou, M. N., Crook, D., Sleeman, K. & Day, N. P. (2003). Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol 41, 57185725.
Regev-Yochay, G., Dagan, R., Raz, M., Carmeli, Y., Shainberg, B., Derazne, E., Rahav, G. & Rubinstein, E. (2004). Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children. JAMA 292, 716720.
Regev-Yochay, G., Trzcinski, K., Thompson, C. M., Malley, R. & Lipsitch, M. (2006). Interference between Streptococcus pneumoniae and Staphylococcus aureus: in vitro hydrogen peroxide-mediated killing by Streptococcus pneumoniae. J Bacteriol 188, 49965001.
Statens Serum Institut (2004). Annual Report on Staphylococcus aureus Bacteraemia Cases 2004. Copenhagen, Denmark: Staphylococcus Laboratory, National Center for Antimicrobials and Infection Control, Statens Serum Institut.
Steinberg, J. P., Clark, C. C. & Hackman, B. O. (1996). Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 23, 255259.[Medline]
van Leeuwen, W. B., Jay, C., Snijders, S., Durin, N., Lacroix, B., Verbrugh, H. A., Enright, M. C., Troesch, A. & van Belkum, A. (2003). Multilocus sequence typing of Staphylococcus aureus with DNA array technology. J Clin Microbiol 41, 33233326.
van Steenbergen, T. J., Colloms, S. D., Hermans, P. W., de Graaff, J. & Plasterk, R. H. (1995). Genomic DNA fingerprinting by restriction fragment end labeling. Proc Natl Acad Sci U S A 92, 55725576.
Veenhoven, R., Bogaert, D., Uiterwaal, C., Brouwer, C., Kiezebrink, H., Bruin, J. E. I. J., Hermans, P., de Groot, R., Zegers, B. & other authors (2003). Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361, 21892195.[CrossRef][Medline]
von Eiff, C., Becker, K., Machka, K., Stammer, H. & Peters, G. (2001). Nasal carriage as a source of Staphylococcus aureus bacteremia. Study group. N Engl J Med 344, 1116.
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A. & Nouwen, J. L. (2005). The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5, 751762.[CrossRef][Medline]
Yu, V. L., Goetz, A., Wagener, M., Smith, P. B., Rihs, J. D., Hanchett, J. & Zuravleff, J. J. (1986). Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 315, 9196.[Abstract]
Received 7 September 2006;
revised 15 November 2006;
accepted 27 November 2006.
This article has been cited by other articles:
![]() |
G. Regev-Yochay, R. Malley, E. Rubinstein, M. Raz, R. Dagan, and M. Lipsitch In Vitro Bactericidal Activity of Streptococcus pneumoniae and Bactericidal Susceptibility of Staphylococcus aureus Strains Isolated from Cocolonized versus Noncocolonized Children J. Clin. Microbiol., February 1, 2008; 46(2): 747 - 749. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |